Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms

doi:10.1016/j.psyneuen.2013.05.020

Psychoneuroendocrinology

Volume 38, Issue 9, September 2013, Pages 1829-1830

https://doi.org/10.1016/j.psyneuen.2013.05.020 Get rights and content

Section snippets

Conflict of interest statement

The author has declared that there are no conflicts of interest.

Acknowledgements

This material is the result of work supported with resources and the use of facilities at the Portland Veterans Affairs (VA) Medical Center, Portland, Oregon. JML is a Research Scientist at the Portland VA Medical Center.

References (8)

R. Dantzer et al.
Inflammation-associated depression: from serotonin to kynurenine
Psychoneuroendocrinology
(2011)
J.M. Loftis et al.
The phenomenology and treatment of interferon-induced depression
J. Affect. Disord.
(2004)
F. Fallarino et al.
Indoleamine 2,3-dioxygenase: from catalyst to signaling function
Eur. J. Immunol.
(2012)
U. Grohmann et al.
IL-6 inhibits the tolerogenic function of CD8^α+ dendritic cells expressing indoleamine 2,3-dioxygenase
J. Immunol.
(2001)

There are more references available in the full text version of this article.

Cited by (0)

View full text

Published by Elsevier Ltd.

Letter to the EditorIndolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms

Section snippets

Conflict of interest statement

Acknowledgements

Psychoneuroendocrinology

J. Affect. Disord.

Indoleamine 2,3-dioxygenase: from catalyst to signaling function

Eur. J. Immunol.

IL-6 inhibits the tolerogenic function of CD8α+ dendritic cells expressing indoleamine 2,3-dioxygenase

J. Immunol.

Letter to the Editor
Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms

IL-6 inhibits the tolerogenic function of CD8^α+ dendritic cells expressing indoleamine 2,3-dioxygenase